Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare.
The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry.
Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.
A sick baby gorilla was nursed back to health in Australia thanks to a zookeeper.
New research has found that younger adults who snore at night are facing some long-term health risks.
New data showed that spending on mental health services jumped over 50% in the early years of the pandemic.
The SpaceX Crew-7 Dragon capsule docked at the International Space Station with a four-astronaut crew.
National weather forecast for Monday, August 28, 2023
Cheddar News checks in with a coast-to-coast forecast of the weather for Friday, August 25, 2023.
There has been a disappearance in fireflies recently in North America.
A recent study showed that there is no clear evidence of a connection between depression and increased social media usage among kids.
The recent wildfires and ensuing smoky air led to a spike in emergency room visits.
A new report shows that some non-paper straws have so-called 'forever chemicals.'
Load More